XML 46 R38.htm IDEA: XBRL DOCUMENT
v3.25.1

Agreement and Plan of Merger - Summary of Total Consideration Paid (Details) - American Depositary Shares - Peak Bio $ in Thousands | Nov. 14, 2024 USD ($) shares
--- | ---
Agreement And Plan Of Merger [Line Items] |
Number of ADSs issued and issuable on exercise | 16,996,592
Consideration | $ | $ 29,973
Company ADSs Issued to Peak Bio Inc. Shareholders |
Agreement And Plan Of Merger [Line Items] |
Number of ADSs issued and issuable on exercise | 12,613,942
Consideration | $ | $ 28,129
Company ADSs Issuable on Exercise of November 2022 Peak Investor Warrants and April 2023 Peak Investor Warrants |
Agreement And Plan Of Merger [Line Items] |
Number of ADSs issued and issuable on exercise | 2,764,569
Consideration | $ | $ 1,844
Company ADSs Issuable on Exercise of Peak Bio Adjusted Options |
Agreement And Plan Of Merger [Line Items] |
Number of ADSs issued and issuable on exercise | 1,618,081

X
- Definition Agreement and plan of merger. + References No definition available. + Details
Name: | aktx_AgreementAndPlanOfMergerLineItems
Namespace Prefix: | aktx_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of equity interests issued or issuable to acquire entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(4) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479581/805-30-50-1 + Details
Name: | us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sic_Z8880
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aktx_PeakBioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=aktx_PeakBioIncShareholdersMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=aktx_NovemberTwoThousandTwentyTwoPeakInvestorWarrantsAndAprilTwoThousandTwentyThreePeakInvestorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=aktx_PeakBioAdjustedOptionsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |